Kennedy Capital Management, Inc. Ovid Therapeutics Inc. Transaction History
Kennedy Capital Management, Inc.
- $3.95 Billion
- Q2 2025
A detailed history of Kennedy Capital Management, Inc. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 1,502,329 shares of OVID stock, worth $826,280. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,502,329
Previous 1,732,865
13.3%
Holding current value
$826,280
Previous $537,000
7.82%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding OVID
# of Institutions
71Shares Held
32.7MCall Options Held
15.6KPut Options Held
0-
Black Rock Inc. New York, NY3.99MShares$2.2 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.12 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.64MShares$1.45 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.23MShares$1.23 Million0.35% of portfolio
-
Acadian Asset Management LLC Boston, MA2.11MShares$1.16 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $38.7M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...